Morgan Stanley’s Vivos Therapeutics VVOS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.37K | Sell |
1,065
-249
| -19% | -$787 | ﹤0.01% | 7130 |
|
|
2025
Q1 | $3.75K | Buy |
1,314
+1,240
| +1,676% | +$3.53K | ﹤0.01% | 7057 |
|
|
2024
Q4 | $317 | Hold |
74
| – | – | ﹤0.01% | 7377 |
|
|
2024
Q3 | $193 | Buy |
74
+6
| +9% | +$16 | ﹤0.01% | 7388 |
|
|
2024
Q2 | $151 | Buy |
68
+1
| +1% | +$2 | ﹤0.01% | 7313 |
|
|
2024
Q1 | $324 | Sell |
67
-67
| -50% | -$324 | ﹤0.01% | 7273 |
|
|
2023
Q4 | $1.67K | Buy |
134
+67
| +100% | +$833 | ﹤0.01% | 7154 |
|
|
2023
Q3 | $320 | Hold |
67
| – | – | ﹤0.01% | 7353 |
|
|
2023
Q2 | $850 | Buy |
67
+11
| +20% | +$140 | ﹤0.01% | 7322 |
|
|
2023
Q1 | $478 | Hold |
56
| – | – | ﹤0.01% | 7443 |
|
|
2022
Q4 | $563 | Hold |
56
| – | – | ﹤0.01% | 7544 |
|
|
2022
Q3 | $1K | Sell |
56
-40
| -42% | -$714 | ﹤0.01% | 7614 |
|
|
2022
Q2 | $3K | Sell |
96
-49
| -34% | -$1.53K | ﹤0.01% | 7531 |
|
|
2022
Q1 | $9K | Buy |
145
+49
| +51% | +$3.04K | ﹤0.01% | 7446 |
|
|
2021
Q4 | $5K | Sell |
96
-5
| -5% | -$260 | ﹤0.01% | 7656 |
|
|
2021
Q3 | $10K | Buy |
101
+42
| +71% | +$4.16K | ﹤0.01% | 7333 |
|
|
2021
Q2 | $7K | Buy |
59
+39
| +195% | +$4.63K | ﹤0.01% | 7328 |
|
|
2021
Q1 | $3K | Sell |
20
-20
| -50% | -$3K | ﹤0.01% | 7224 |
|
|
2020
Q4 | $6K | Buy |
+40
| New | +$6K | ﹤0.01% | 6750 |
|